Cliff Stocks: Founder and CEO of OncoResponse

from BioBoss · host Cliff Stocks

Cliff Stocks, founder and CEO of OncoResponse speaks with BioBoss host John Simboli. Hear Cliff’s insights about leadership in biopharma and how OncoResponse is working to identify fully human monoclonal antibodies as therapeutics for the treatment of cancer.

Episode metadata supplied by the publisher feed · Published Aug 17, 2022

Embed this episode

Attribution link and audio player

Ready to play

Cliff Stocks: Founder and CEO of OncoResponse

0:00 34:47

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of BioBoss?

This episode is 34 minutes long.

When was this BioBoss episode published?

This episode was published on August 17, 2022.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this BioBoss episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!